IQ has been reported to exert its anticancer activity via a GADD153-mediated pathway in prostate cancer cells and promote TRAIL-induced apoptosis via ROS-ERK/p38 MAPK-CHOP pathways in human colon cancer cells [15,16]. Here, DDIT3 is linked to prostate carcinoma.